Cargando…
The relationship between serum exosome HBV-miR-3 and current virological markers and its dynamics in chronic hepatitis B patients on antiviral treatment
BACKGROUND: Hepatitis B virus (HBV) can encode microRNA-HBV-miR-3, which can be detected in both HBV-infected cell lines and peripheral blood exosomes of chronic hepatitis B (CHB) patients. This study was conducted to further evaluate its relationship with the current viral markers and their dynamic...
Autores principales: | Gan, Weiqiang, Chen, Xi, Wu, Zeqian, Zhu, Xiang, Liu, Jing, Wang, Tong, Gao, Zhiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201139/ https://www.ncbi.nlm.nih.gov/pubmed/35722385 http://dx.doi.org/10.21037/atm-22-2119 |
Ejemplares similares
-
Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure
por: Gan, Weiqiang, et al.
Publicado: (2023) -
HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023) -
Treatment of chronic HBV hepatitis – between immune control and virological control
por: Popescu, Cristina, et al.
Publicado: (2014) -
Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990) -
Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B
por: Song, Joon Chang, et al.
Publicado: (2011)